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Abstract
Background: The diagnostic performance of adenosine stress cardiovascular magnetic resonance (CMR) in patients
with arrhythmias presenting for work-up of suspected or known CAD is largely unknown, since most CMR studies
currently available exclude arrhythmic patients from analysis fearing gating problems, or other artifacts will impair
image quality. The primary aim of our study was to evaluate the diagnostic performance of adenosine stress CMR
for detection of significant coronary stenosis in patients with arrhythmia presenting for 1) work-up of suspected
coronary artery disease (CAD), or 2) work-up of ischemia in known CAD.
Methods: Patients with arrhythmia referred for work-up of suspected CAD or work-up of ischemia in known CAD
undergoing adenosine stress CMR were included if they had coronary angiography within four weeks of CMR.
Results: One hundred fifty-nine patients were included (n = 64 atrial fibrillation, n = 87 frequent ventricular
extrasystoles, n = 8 frequent supraventricular extrasystoles). Of these, n = 72 had suspected CAD, and n = 87 had
known CAD. Diagnostic accuracy of the adenosine stress CMR for detection of significant CAD was 73 % for the
entire population (sensitivity 72 %, specificity 76 %). Diagnostic accuracy was 75 % (sensitivity 80 %, specificity 74 %)
in patients with suspected CAD, and 74 % (sensitivity 71 %, specificity 79 %) in the group with known CAD. For
different types of arrhythmia, diagnostic accuracy of CMR was 70 % in the atrial fibrillation group, and 79 % in
patients with ventricular extrasystoles. On a per coronary territory analysis, diagnostic accuracy of CMR was 77 % for
stenosis of the left and 82 % for stenosis of the right coronary artery.
Conclusion: The present data demonstrates good diagnostic performance of adenosine stress CMR for detection of
significant coronary stenosis in patients with arrhythmia presenting for work-up of suspected CAD, or work-up of
ischemia in known CAD. This holds true for a per patient, as well as for a per coronary territory analysis.
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Background
Coronary artery disease (CAD) is the leading cause of
death in the western world [1]. Current clinical practice
guidelines recommend noninvasive stress testing for 1)
work-up of suspected CAD [2], and 2) work-up of ische-
mia in known CAD [3].
Adenosine stress cardiovascular magnetic resonance
(CMR) is a noninvasive stress-testing modality offering
high diagnostic accuracy without need for radiation or
acoustic window [4–7]. However, up to 90 % of patients
with CAD suffer from frequent ventricular ectopic beats
[8], and/or other arrhythmias [9, 10]. Unfortunately, the
diagnostic performance of adenosine stress CMR in this
important subgroup is widely unknown, since most
CMR studies currently available exclude arrhythmic pa-
tients from analysis [6, 11–13] fearing gating problems,
or other artifacts will impair image quality [14].
Thus, our primary aim was to evaluate the diagnostic
performance of adenosine stress CMR for detection of
significant coronary stenosis in patients with arrhythmia
presenting for 1) work-up of suspected CAD, or 2)
work-up of ischemia in known CAD. In addition, we
aimed to assess the diagnostic performance of adenosine




All patients referred for 1) work-up of suspected CAD,
and 2) work-up of ischemia in known CAD undergoing
adenosine stress CMR at our institution between January
2011 and June 2014 were prospectively screened for
study enrolment on a consecutive basis. We included all
patients with arrhythmia during the stress CMR proced-
ure (see definition of arrhythmia below), who underwent
invasive coronary angiography within 4 weeks before or
after the stress CMR, and who gave written informed con-
sent to the protocol, which was approved by the local insti-
tutional review board (University of Tübingen, Germany).
Exclusion criteria for the analysis were collateralized total
occlusions revealed by coronary angiography, since in those
cases no ischemia may be present despite occlusion, non-
diagnostic images due to breathing artifacts, withdrawal of
consent before completion of procedure, or other technical
problems (Fig. 1). Baseline characteristics of the patient
population can be viewed in Table 1.
Definitions
Relevant coronary stenosis/CAD was defined as ≥70 %
narrowing of the luminal diameter in at least one projec-
tion of at least one major epicardial artery, or ≥50 % nar-
rowing of the left main [2].
Suspected CAD: Patients without prior history of CAD.
Known CAD: Patients with prior myocardial infarction
and/or revascularization procedure(s) such as percutan-
eous coronary intervention (PCI) or coronary artery by-
pass graft (CABG).
CAD-type late gadolinium enhancement (LGE): Sub-











n=4: Severe breathing artifacts
n=1: Only stress, no rest perfusion
n=1: Claustrophobia
n=1: Technical problems
Fig. 1 Flow chart demonstrating the study population
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Table 1 Baseline characteristics
Entire group Suspected CAD Known CAD p
(n = 159) (n = 72) (n = 87)
Age (yrs) 71.1 ± 10 69.9 ± 10.4 72.2 ± 9.6 0.17
Gender (female) 55 (35 %) 39 (54 %) 16 (18 %) <0.05
CAD Risk Factors
Diabetes 51 (32 %) 20 (28 %) 31 (36 %) 0.31
Hypertension 127 (80 %) 58 (81 %) 69 (79 %) 1
Smokinga 49 (31 %) 18 (25 %) 31 (36 %) 0.17
Hyperlipidemia 105 (66 %) 39 (54 %) 66 (76 %) 0.004
Family history of CVD 55 (35 %) 24 (33 %) 31 (36 %) 0.74
Menopauseb 52 (95 %)b 37 (95 %)b 15 (94 %)b 1
Obesity (BMI≥ 30 kg/m2) 30 (19 %) 17 (24 %) 13 (15 %) 0.15
Number of risk factors 2.9 ± 1.2 2.9 ± 1.3 3.0 ± 1.2 0.53
Cardiac Arrhythmia
Heart rate at rest (beats/min.) 67 [60–78] 68 [60–80] 66 [59–78] 0.71
Heart rate at stress (beats/min.) 85 [77–99] 85 [78–101] 85 [77–98] 0.89
Atrial fibrillation 64 (40 %) 32 (44 %) 32 (37 %) 0.34
VES 87 (55 %) 35 (49 %) 52 (60 %) 0.20
Couplets 15 (9 %) 4 (6 %) 11 (13 %) 0.18
Triplets 6 (4 %) 2 (3 %) 4 (5 %) 0.69
Bigeminus 32 (20 %) 12 (17 %) 20 (23 %) 0.43
Trigeminus 6 (4 %) 3 (4 %) 3 (3 %) 1
SVES 8 (5 %) 5 (7 %) 3 (3 %) 0.47
Medication
Statins 92 (58 %) 34 (47 %) 58 (67 %) 0.03
Beta-blockers 100 (63 %) 38 (53 %) 62 (71 %) 0.03
Aspirin 93 (59 %) 34 (47 %) 59 (68 %) 0.02
ARB 105 (66 %) 41 (57 %) 64 (74 %) 0.06
Nitrates 37 (23 %) 12 (17 %) 25 (29 %) 0.13
Diuretics 77 (48 %) 31 (43 %) 46 (53 %) 0.33
Symptoms (multiple possible)
Chest pain 107 (67 %) 43 (60 %) 64 (74 %) 0.43
Dyspnea 87 (55 %) 46 (64 %) 41 (47 %) 0.04
Palpitations 16 (10 %) 9 (13 %) 7 (8 %) 0.09
Syncope 10 (6 %) 5 (7 %) 5 (6 %) 0.75
Reduced LV-EF 56 (35 %) 23 (32 %) 33 (38 %) 0.61
ECG abnormality 105 (66 %) 37 (51 %) 68 (78 %) <0.001
Wall motion abnormality 46 (29 %) 12 (17 %) 34 (39 %) 0.02
Values are n (%), mean ± SD or median [IQR]
suspected CAD CMR work-up of suspected CAD in patients without history of CAD, known CAD CMR work-up of ischemia in patients with prior myocardial infarction
and/or revascularization procedure (PCI or CABG), CAD coronary artery disease, PCI percutaneous coronary intervention, CABG coronary artery bypass graft, CVD
cardiovascular disease, BMI body mass index, VES ventricular extrasystoles, SVES supraventricular extrasystoles, ARB angiotensin receptor blocker, CMR cardiac
magnetic resonance, LV-EF left ventricular ejection fraction, ECG electrocardiography
aCurrent or ever-smokers
bCalculated for females
Greulich et al. Journal of Cardiovascular Magnetic Resonance  (2015) 17:94 Page 3 of 11
Arrhythmia was defined as atrial fibrillation, and/or
frequent ectopic beats >20/min (of ventricular or supra-
ventricular origin) [13]. All arrhythmias were detected
by ECG and/or Holter ECG, and had to be present dur-
ing both adenosine stress and rest perfusion.
Analysis per coronary territory was made on a 17 seg-
ment model basis according to AHA guidelines as previ-
ously described [16]. Left coronary artery (LCA) included
the following coronary arteries: left main (LM), left anter-
ior descending (LAD) and left circumflex artery (LCX).
CMR protocol
Electrocardiogram (ECG) gated CMR imaging was per-
formed in breath-hold using a 1.5 T Magnetom Aera
(Siemens-Healthcare, Germany) in line with recommen-
dations of the Society of Cardiac Magnetic Resonance,
and the European Society of Cardiology Working Group
EuroCMR, respectively [17].
Details of the CMR protocol have been reported previ-
ously [18]. In brief, steady-state free-precession cine im-
ages for assessment of LV function were acquired in
multiple short-axis (every 10 mm throughout the LV) and
three long-axis views. Adenosine (140 μg · kg−1 · min−1)
was infused under continuous electrocardiography and
blood pressure monitoring for approximately 3 min. At
2.5 min into the infusion, gadolinium (0.07 mmol/kg
Gadodiamide or Gadopentetate-Dimeglumine) first-pass
imaging for assessment of stress perfusion was performed
in three short axis views (basal, mid, apical, matched to
cine locations excluding most basal and apical slices) using
a saturation-recovery, single-shot, gradient-echo sequence
(90° pre-pulse before each slice; echo time, 1.1 ms; delay
time, 85–100 ms; temporal resolution, 110–125 ms; voxel
size, 3.0 × 1.8 × 8.0 mm). In order to speed up imaging
parallel imaging with 2-fold acceleration was employed.
Repeat first-pass images without adenosine 15 min later
were performed for assessment of rest perfusion. Five mi-
nutes after rest perfusion (additional 0.07 mmol/kg Gado-
diamide or Gadopentetate-Dimeglumine), late gadolinium
enhancement was performed using a segmented inversion-
recovery technique in the identical views as cine-CMR.
The image acquisition protocol was completed in about
45 min.
CMR analysis
Scans were analyzed by consensus of two experienced ob-
servers (S.G., H.M.), who were blinded to patient identity,
clinical information, and the angiography results. A perfu-
sion defect was defined as a regional dark area, that 1)
persisted for >2 beats while other regions enhanced during
the first-pass of contrast through the myocardium, and 2)
involved the subendocardium [19, 20]. Dark rim artifact
was not regarded as perfusion deficit using previously de-
scribed criteria [21].
Cine and contrast images were evaluated as described
elsewhere [22]. In brief, endocardial and epicardial bor-
ders were outlined on the short axis cine images. Vol-
umes and ejection fraction were derived by summation
of epicardial and endocardial contours.
In patients referred for work-up of suspected CAD the
Duke algorithm was used for diagnosis of CAD [18]: Pa-
tients were diagnosed having relevant stenosis/CAD if
they had 1) evidence of LGE consistent with a prior
myocardial infarction, or 2) no evidence of prior myo-
cardial infarction, but perfusion defects present with ad-
enosine that were absent or reduced at rest (reversible
perfusion defect). If patients showed a matched perfu-
sion defect under stress and rest perfusion, patients were
considered having no relevant stenosis/CAD [18].
In patients referred for work-up of ischemia in known
CAD two different algorithms were used depending on
the presence of ischemic scar: 1) In the absence of ische-
mic scar on LGE images relevant stenosis/ischemia was
defined as the presence of a reversible perfusion defect
as described above [18]. 2) In the presence of ischemic
scar on LGE images ischemia was defined as a mismatch
between the first-pass stress perfusion defect and en-
hancement seen on LGE sequences, whereas a match
between the first-pass stress perfusion defect and LGE
was considered as chronic myocardial infarction with no
additional reversible ischemia [23].
Coronary angiography and analysis by coronary artery
territory
Coronary angiography was performed by standard tech-
niques [24] and analyzed masked to identity, clinical in-
formation, and CMR results. Significant CAD was
defined as ≥70 % narrowing of the luminal diameter in
at least one projection of at least one major epicardial
artery, or ≥50 % narrowing of the left main [2]. Native
vessels with a diameter smaller than 2 mm were ex-
cluded from the analysis. Two experienced interven-
tional cardiologists (S.G, H.M.) blinded to the results of
the CMR imaging visually evaluated the coronary angio-
grams by consensus.
Statistical analysis
Absolute numbers and percentages were computed to
describe the patient population. All continuous variables
were tested for normality. Normally distributed continu-
ous variables were expressed as means (with standard
deviation) and skewed variables were presented as me-
dians (with quartiles). Comparisons between groups were
made using the Mann-Whitney U test or the Fisher’s exact
test, as appropriate. Statistical tests were two-tailed; p-
value < 0.05 was considered significant. Positive and nega-
tive likelihood ratios (LR) were calculated. All statistical
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analyses were performed using SPSS, version 22.0 (IBM
Corp., Armonk, NY, USA).
Results
Patient characteristics
In total 159 patients were included in the final analysis
(Fig. 1). Table 1 summarizes the patient characteristics.
At inclusion, patients were 71 ± 10 years of age and pre-
dominantly male (65 %). Atrial fibrillation was present in
64 patients (40 %), 87 patients (55 %) suffered from fre-
quent ventricular extrasystoles (VES), and 8 patients
(5 %) showed frequent supraventricular extrasystoles
(SVES). The majority (67 %) had chest pain as primary
reason to suspect significant CAD, followed by dyspnea
(55 %), and palpitations (10 %).
Seventy-two patients were referred for work-up of sus-
pected CAD, and 87 patients were referred for work-up
of ischemia in known CAD. The group with known
CAD was older (72.2 ± 9.6) with fewer females (18 %)
than the group with suspected CAD (age 69.9 ± 10.4,
p = 0.17; 54 % females, p < 0.05). Patients presenting
with known CAD had a higher prevalence of hyperlipid-
emia (p = 0.004), and wall motion abnormalities (p = 0.02)
than patients with suspected CAD. Of note, the preva-
lence of the different types of arrhythmia was similar be-
tween the two groups.
General CMR findings
General CMR results are displayed in Table 2. Left ven-
tricular ejection fraction (LV-EF) in the study population
was mildly impaired (median 54 %) with normal mean
cardiac volumes. Overall, CMR perfusion revealed LCA
ischemia in 31 %, and RCA ischemia in 23 % of patients.
CAD-type LGE was present in 47 % of patients.
Among patients with known CAD, LV-EF was signifi-
cantly lower compared to the suspected CAD group,
p = 0.04. Conversely, left ventricular end-diastolic vol-
umes (LV-EDV) and left ventricular end-systolic volumes
(LV-ESV) were significantly larger in the known CAD
group (LV-EDV p = 0.01, LV-ESV p = 0.007 respectively).
In addition, patients with known CAD were diagnosed
with relevant stenosis/ischemia more frequently than pa-
tients with suspected CAD (p = 0.001, p < 0.001, respect-
ively). CAD-type LGE was also more common in the
known CAD group (68 vs. 21 %, p < 0.001).
Diagnostic performance of CMR
Entire population
Overall diagnostic accuracy of adenosine stress CMR for
the detection of ≥70 % stenosis on coronary angiography
was 73 % (sensitivity 72 %, specificity 76 %) for patients
with suspected or known CAD (Table 3). On a per cor-
onary territory basis the diagnostic accuracy of CMR
was 77 % for LCA stenosis (sensitivity 78 %, specificity
77 %) and 82 % for detection of RCA stenosis (sensitivity
63 %, specificity 88 %).
Table 2 CMR results
Parameter Entire group Suspected CAD Known CAD p
(n = 159) (n = 72) (n = 87)
LV-EF (%) 54 [39–66] 61 [45–67] 50 [34–64] 0.04
LV-EDV (ml) 124 [101–168] 116 [91–145] 133 [106–181] 0.01
LV-ESV (ml) 54 [32–98] 49 [28–69] 68 [40–109] 0.007
LA (cm2) 26 [21–35] 27 [22–38] 26 [21–34] 0.43
IVS (mm) 12 [10–13] 11 [10–13] 12 [10–14] 0.58
Ischemia LCA 49 (31 %) 13 (18 %) 36 (41 %) 0.001
Ischemia RCA 36 (23 %) 7 (10 %) 29 (33 %) <0.001
CAD-type LGE 74 (47 %) 15 (21 %) 59 (68 %) <0.001
Values are median [IQR], or n (%)
CAD coronary artery disease, suspected CAD CMR work-up of suspected CAD in
patients without history of CAD, known CAD CMR work-up of ischemia in
patients with prior myocardial infarction and/or revascularization procedure (PCI
or CABG), LV left ventricular, EF ejection fraction, EDV end-diastolic volume, ESV
end-systolic volume, LA left atrium, IVS interventricular septum, LCA LM+ LAD +
LCX, LCA left coronary artery, LM left main, LAD left anterior descending, LCX left
circumflex artery, LGE late gadolinium enhancement
Table 3 Diagnostic performance of CMR stress testing for the
detection of ≥70 % stenosis on coronary angiography in all
patients (n = 159)
Per patient LCAa RCA
All Types of Arrhythmiab
Sensitivity 72 % (49/68) 78 % (53/68) 63 % (24/38)
Specificity 76 % (69/91) 77 % (70/91) 88 % (107/121)
Diagnostic
Accuracy
73 % (118/159) 77 % (123/159) 82 % (131/159)
LR+ 3.00 3.39 5.25
LR- 0.37 0.29 0.42
AFib Only
Sensitivity 71 % (25/35) 81 % (22/27) 63 % (10/16)
Specificity 69 % (20/29) 76 % (28/37) 88 % (42/48)
Diagnostic
Accuracy
70 % (45/64) 78 % (50/64) 81 % (52/64)
LR+ 2.29 3.38 5.25
LR- 0.42 0.25 0.42
VES Only
Sensitivity 74 % (23/31) 75 % (30/40) 65 % (13/20)
Specificity 82 % (46/56) 81 % (38/47) 90 % (61/67)
Diagnostic
Accuracy
79 % (69/87) 78 % (68/87) 85 % (74/87)
LR+ 4.11 3.95 6.05
LR- 0.32 0.31 0.39
Values are % (n)
AFib atrial fibrillation, VES ventricular extrasystoles, SVES supraventricular
extrasystoles, LR+ positive likelihood ratio, LR- negative likelihood ratio
aLCA = LM + LAD + LCX, abbreviations see Table 2
bAll types of arrhythmia: n = 64 AFib + n = 87 VES + n = 8 SVES
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Looking at patients presenting with atrial fibrillation
(n = 64) revealed a diagnostic accuracy of 70 % for CMR
(sensitivity 71 %, specificity 69 %), which is lower than in
the 87 patients presenting with VES (diagnostic accuracy
79 %, sensitivity 74 %, specificity 82 %). On a per coron-
ary territory basis, the diagnostic accuracy for detection
of LCA and RCA stenosis was good in patients with
atrial fibrillation (78 %, 81 % respectively), and in pa-
tients with VES (78 %, 85 % respectively).
Considering the low number of patients with SVES
(n = 8), these patients were included in the entire popula-
tion analysis. Five of those patients were in the suspected
CAD group, and three out of five were classified cor-
rectly as negative by CMR. The other three patients
had known CAD, two of them had coronary stenosis
on coronary angiography, one of them was correctly
identified by CMR.
Patients with suspected CAD
Diagnostic accuracy of CMR stress testing for the detec-
tion of ≥70 % stenosis in patients with suspected CAD
was 75 % (sensitivity 80 %, specificity 74 %), positive
likelihood ratio (LR) 3.08, negative LR 0.27 (Table 4).
The prevalence of significant coronary stenosis on cor-
onary angiography was 14 % (10 out of 72 patients with
suspected CAD).
CMR identified 80 % of the patients with suspected
CAD and stenosis of the LCA correctly, yielding to a
diagnostic accuracy of 76 % (specificity 76 %), positive
LR 3.33 and negative LR 0.26. For the RCA, CMR re-
vealed a diagnostic accuracy of 89 %, with a sensitivity of
100 %, and a specificity of 89 %, positive LR 8.33, nega-
tive LR 0. Figure 2 demonstrates two typical patients
with suspected CAD and different types of arrhythmia.
Patients with known CAD
The diagnostic accuracy of CMR stress for detection of
≥70 % stenosis in patients with known CAD was 74 %
(sensitivity 71 %, specificity 79 %), positive LR 3.38,
negative LR 0.37, see Table 5. The prevalence of signifi-
cant coronary stenosis on coronary angiography was
67 % (58 out of 87 patients with known CAD).
CMR identified 78 % of patients with known CAD and
stenosis ≥70 % in the LCA correctly, yielding a diagnos-
tic accuracy of 78 % and a specificity of 79 %, positive
LR 3.71, and negative LR 0.28. For the RCA, CMR re-
vealed a diagnostic accuracy of 77 %, with a sensitivity of
62 %, and a specificity of 88 %, positive LR 5.17, negative
LR 0.43. Typical CMR results are displayed in Fig. 3
Discussion
To the best of our knowledge, this is the first study
evaluating the diagnostic performance of adenosine
stress CMR for detection of significant coronary stenosis
in patients with different types of arrhythmia. Our data
indicate that adenosine stress CMR performs well for
detection of relevant coronary stenosis in patients with
suspected CAD (diagnostic accuracy 75 %), and also in
patients with known CAD (diagnostic accuracy 74 %),
despite the presence of various arrhythmias during the
CMR procedure. These results underscore the increasing
value of adenosine stress CMR in the real world clinical
routine.
Patient characteristics
The average patient age and gender distribution are
similar to previous stress CMR studies in which patients
with arrhythmia where usually excluded from analysis
[5]. This also holds true for the clinical symptoms lead-
ing to CMR referral in the present population [25].
Types of arrhythmia found in our patients include atrial
fibrillation, frequent VES and frequent SVES, which are
known to be associated with CAD [8–10]. As to expect,
the subgroup with known CAD was older (72.2 ±
9.6 years), with fewer females (18 %) and higher preva-
lence of hyperlipidemia than the group with suspected
CAD (69.9 ± 10.4 years, p = 0.17; 54 % females, p < 0.05).
General CMR findings
Median LV-EF of all patients was 54 %, which is compar-
able to other studies evaluating the diagnostic perform-
ance of adenosine stress CMR in a mixed patient
population comprising patients with suspected and
known CAD [23]. Patients with known CAD had a lower
LV-EF and larger end-diastolic and end-systolic volumes,
most likely explained by the higher prevalence of ische-
mic scar represented by CAD-type LGE (68 vs. 21 % in
the suspected CAD group), resulting in reduced LV-EF
and ventricular remodeling. Ischemia was also more
common in patients with known CAD than in the group
with suspected CAD, respectively.
Table 4 Diagnostic performance of CMR stress testing for the
detection of ≥70 % stenosis on coronary angiography in
patients with suspected CAD by use of the Duke algorithma
Per patient LCAb RCA
Sensitivity 80 % (8/10) 80 % (8/10) 100 % (1/1)
Specificity 74 % (46/62) 76 % (47/62) 89 % (63/71)
Diagnostic Accuracy 75 % (54/72) 76 % (55/72) 89 % (64/72)
LR+ 3.08 3.33 8.33
LR- 0.27 0.26 0
Values are % (n)
suspected CAD CMR work-up of suspected CAD in patients without history of CAD
aPresence of CAD-type LGE or stress induced perfusion defect
bLCA = LM + LAD + LCX; n = 32 AFib + n = 35 VES + n = 5 SVES; other
abbreviations see Table 3
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Diagnostic performance of CMR
Entire population
Looking at the entire population, the diagnostic accuracy
of stress CMR for the detection of ≥70 % stenosis on
coronary angiography was 73 % (sensitivity 72 %, specifi-
city 76 %) for all 159 patients with suspected or known
CAD, and different types of arrhythmia. This is lower
than reported in a large meta-analysis [5] calculating a
sensitivity of 90 % and a specificity of 81 %. However,
many studies of this meta-analysis excluded patients
with arrhythmia to improve image quality, which most
likely explains the difference to our data based on pa-
tients presenting with arrhythmia only.
Analyzing our entire population data per coronary terri-
tory demonstrate CMR to yield a diagnostic accuracy of
77 % for the LCA (sensitivity 78 %, specificity 77 %), and
of 82 % for the RCA (sensitivity 63 %, specificity 88 %).
This is also lower than in the meta-analysis mentioned
above, demonstrating sensitivities of 83, 76 and 78 % and
specificities of 83, 87, and 87 % for LAD, LCX and RCA,
respectively. However, patients with arrhythmias were ex-
cluded in most studies of this meta-analysis [5].
Comparing patients with atrial fibrillation to patients
with VES (Table 3) reveals a good diagnostic accuracy
for LCA and RCA (78 and 81 %) in the atrial fibrillation
group, and in patients with VES (78 and 85 %). However,
























Stress Rest LGE Cath
Fig. 2 Patients with suspected CAD, but different types of arrhythmia: Top row: 72-year old male with atrial fibrillation presenting for work-up of
suspected CAD. CMR revealed no LGE, but a reversible perfusion defect at the inferoseptal wall (white arrows), highly suggestive of significant
RCA stenosis. Coronary angiography revealed high-grade RCA stenosis (black arrow). Bottom row: 69-year old female with frequent VES and
atypical chest pain presenting for work-up of suspected CAD. LGE was negative, stress perfusion revealed no perfusion defect, resulting in the
CMR diagnosis “no CAD”. Coronary angiography confirmed unobstructed coronary arteries
Table 5 Diagnostic performance of CMR stress testing for the
detection of ≥70 % stenosis on coronary angiography in patients
with known CAD
Per patient LCAa RCA
Sensitivity 71 % (41/58) 78 % (45/58) 62 % (23/37)
Specificity 79 % (23/29) 79 % (23/29) 88 % (44/50)
Diagnostic Accuracy 74 % (64/87) 78 % (68/87) 77 % (67/87)
LR+ 3.38 3.71 5.17
LR- 0.37 0.28 0.43
Values are % (n)
known CAD CMR work-up of ischemia in patients with prior myocardial infarction
and/or revascularization procedure (PCI or CABG)
aLCA = LM + LAD + LCX, n = 32 AFib + n = 52 VES + n = 3 SVES, abbreviations
see Table 3
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lower in both groups when compared to the LCA (atrial
fibrillation 63 vs. 81 %, VES 65 vs. 75 %). This is in ac-
cordance with other studies [5], reporting a higher sensi-
tivity for detection of stenosis in the LAD when
compared to LCX and RCA, most likely due to the sur-
face radiofrequency coil receiving lower signal intensities
from the inferior and lateral segments [5].
Patients with suspected CAD
Evaluating the subgroup presenting for work-up of sus-
pected CAD the diagnostic accuracy was 75 % (sensitivity
80 %, specificity 74 %). This is less than reported by Klem
et al. [18], who first described the Duke algorithm for
work-up of suspected CAD by combining LGE and perfu-
sion sequences in 92 patients. However, in contrast to the
present data, the Klem population only included one pa-
tient with atrial fibrillation and two patients with VES.
Among our 72 patients with suspected CAD the
prevalence of significant coronary stenosis was low
(14 %), underscoring the need of noninvasive imaging in
patients with arrhythmia before undergoing coronary
angiography. One reason for the low prevalence of CAD
might be that patients with arrhythmia are at an “in-
creased risk” to be referred to coronary angiography due
to previous inconclusive exercise tests, or the presence
of arrhythmia itself in combination with risk factors and
complaints. Interestingly, this finding nicely matches the
results of Smit et al. who performed a myocardial perfu-
sion single photon emission computed tomography
(SPECT) analysis in patients with atrial fibrillation and
suspected CAD. The prevalence of CAD (≥70 % sten-
osis) in this group was 13 % [26].
In a per coronary territory analysis, the diagnostic ac-

























Fig. 3 Patients with known CAD. Top row: 71-year old female with atrial fibrillation and known CAD (myocardial infarction two years ago)
presented for work-up of new ischemia. LGE revealed a transmural infarction of the inferior wall. Stress perfusion demonstrated a reversible
perfusion defect of the lateral wall (white arrows), highly suggestive of significant LCX stenosis. This could be confirmed by coronary angiography:
LCX had a high-grade proximal stenosis (white arrow), RCA showed coronary plaques, but no significant stenosis. Bottom row: 73-year old male
with typical angina, frequent VES, and known CAD (prior stenosis of the LAD, in which PCI was performed 12 years ago). LGE revealed no scar,
but stress perfusion demonstrated a large perfusion defect in the lateral wall, suggestive of LCX stenosis. On coronary angiography, severe LCX
stenosis could be confirmed
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76 %). For the RCA our data revealed a diagnostic accur-
acy of 89 % (sensitivity 100 %, specificity 89 %), com-
pletely in line with the results of Klem et al. [18].
However, it must be noted that only one patient with
suspected CAD had ≥70 % RCA stenosis.
Patients with known CAD
Focusing on the subgroup with known CAD the diag-
nostic accuracy of CMR stress testing for the detection
of ≥70 % stenosis was 74 % (sensitivity 71 %, specificity
79 %). A study by Klein et al. investigated the diagnostic
performance of adenosine perfusion CMR in 78 patients
[27] reporting a diagnostic accuracy of 82 % for detec-
tion of ≥50 % stenosis (sensitivity 77 %, specificity 90 %),
excluding patients with atrial fibrillation.
Per coronary territory the diagnostic accuracy for the
LCA was 78 and 77 % for the RCA, which is also quite
in line with other reports [23, 27]. Figure 4 demonstrates
the feasibility of adenosine stress CMR in a patient pre-
senting with frequent VES (bigeminus).
Limitations
Limitations of the present study are, that adenosine stress
CMR was compared with invasive coronary angiography,
which is not the perfect gold standard for comparison as
functional significance of coronary obstruction and lu-
minal diameter stenosis are known to show only moderate
correlation. Furthermore, it is important to keep in mind
that the algorithm used for CMR analysis of patients with
suspected CAD is intended to detect significant obstruc-
tion of the epicardial coronaries compared to invasive cor-
onary angiography (>70 % stenosis). Thus, perfusion
defects that were considered as artifacts according to the
algorithm used in this analysis may be a surrogate param-
eter for microvascular dysfunction. Hence, it might be
possible that these patients who suffer partly from distinct
anginal symptoms were classified as healthy by CMR,
which could be confirmed by coronary angiography. An-
other limitation is the selection bias introduced by exclud-
ing patients with collateralized occlusions and CMR
studies with severe breathing artifacts. Despite introducing
a bias, we believe that the exclusion of collateralized oc-
clusions is favorable in order to keep the data consistent,
since in those cases no ischemia may be present despite
occlusion of the vessel. Furthermore, removal of CMR
data sets due to severe breathing artifacts seems reason-
able since aim of our study was to evaluate the impact of
arrhythmia (and not of severe breathing artifacts) on the
diagnostic accuracy of an adenosine stress CMR test.
Moreover, it should be stated that only a few patients (4
out of 163 patients, =0.02 %) were excluded due to severe
breathing artifacts.
Clinical implications
On the basis of the data presented it may be safe to as-
sume that the diagnostic performance of adenosine
stress CMR for detection of significant coronary sten-


















Fig. 4 Two CMR exams with two different rhythms in one and the same patient. 77-year old male undergoing stress CMR two times within four
weeks due to LAD in-stent restenosis early after intervention. One scan was performed during bigeminus (upper row), whereas the second scan
was performed in sinus rhythm (bottom row). Note that the stress perfusion defect in the LAD territory (left column) could be detected in sinus
rhythm, as well as during bigeminus
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arrhythmias compared to patients without arrhythmias
(75 vs. 88 % for suspected CAD [18] and 74 vs. 82 % in
known CAD [27]), but still sufficient for clinical routine
use. In fact, with a sensitivity of 72 %, and specificity of
76 % (overall diagnostic accuracy of 73 %) adenosine stress
CMR in patients with arrhythmias performs well in com-
parison to other stress testing modalities (SPECT: sensitiv-
ity 73–92 %, specificity 63–87; stress echocardiography:
sensitivity 80–85 %, specificity 80–88 %; exercise ECG:
sensitivity 45–50 %, specificity 85–90 %) [2], underscoring
the value of adenosine stress CMR in a real world clinical
setting.
Unfortunately, the current study was not designed to
evaluate the prognostic value of stress CMR in patients
with arrhythmias. However, given the encouraging re-
sults with regard to the diagnostic performance in those
patients, and the results of the EuroCMR Registry dem-
onstrating a good prognostic value of adenosine stress
CMR in patients presenting for work-up of suspected
CAD [28], including those with arrhythmias, it is likely
that adenosine stress CMR also has a good prognostic
value in arrhythmic patients. Nevertheless, additional
data is needed to underscore this important point.
Conclusions
The present data demonstrates a good diagnostic per-
formance of adenosine stress CMR for detection of sig-
nificant coronary stenosis in patients with arrhythmia
presenting for 1) work-up of suspected CAD, or 2)
work-up of ischemia in known CAD. This holds true in
the entire population for a per patient, as well as a per
coronary territory analysis.
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